Viking Therapeutics (VKTX) Market Cap 2015–2026

As of October 29, 2026, Viking Therapeutics had a market cap of $3.425 billion, which increased by 15.79% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Oct 29, 2026, 4:00 PM ET
Viking Therapeutics logo

Viking Therapeutics Inc. (VKTX)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$3.425B ▲ 15.79%
Start of 2026
$3.977B ▼ 13.88%
1 Year Ago
$4.315B ▼ 20.63%
All-Time High
$9.989B ▼ 65.71%


Loading data...


Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Viking Therapeutics Market Cap History by Year and Month

Viking Therapeutics Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$3.425B▼ 13.88%
$3.425B▼ 9.94%
$3.803B▼ 0.55%
$3.824B▲ 3.27%
$3.703B▼ 18.09%
$4.521B▲ 18.94%
$3.801B▲ 5.17%
$3.614B▼ 3.88%
$3.76B▼ 3.84%
$3.91B▲ 19.10%
$3.283B▼ 17.45%
2025$3.977B▼ 11.43%
2024$4.49B▲ 141.14%
2023$1.862B▲ 158.25%
2022$0.721B▲ 100.28%
All market cap values reflect closing prices for the period shown.

📊 Viking Therapeutics Market Cap and Other Industry Peers

Below are selected companies from the Biotechnology sector / subsector:


Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.